glp 1 and diabetic retinopathy GLP-1 receptor agonists are transforming metabolic care. Ophthalmologists now need to understand the ocular signals emerging around these drugs., The strongest safety discussion involves The Link between GLP-1 Drugs

Nomura S, Katoh H, Yanagisawa S, Noguchi T, Okada K, Watanabe M (2023) Administration of the GLP-1 receptor agonist exenatide in rats improves functional recovery after spinal cord injury by reducing endoplasmic reticulum stress

The reduced appetite and early satiety from GLP-1 medications can make this challenging

Key metabolic hormones (including glucagon-like peptide-1 (GLP-1), leptin, ghrelin, and cholecystokinin (CCK) play dual roles: not only regulating hunger and metabolism, but also directly modulating the activity and expression of taste receptors throughout the oral cavity and gastrointestinal tract

How could one drug potentially help with so many different health problems

We routinely reevaluate the recommendations in this guide

The deeper issue is about the persistence of dietary change